Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women.

Rours GI, Smith-Norowitz TA, Ditkowsky J, Hammerschlag MR, Verkooyen RP, de Groot R, Verbrugh HA, Postma MJ.

Pathog Glob Health. 2016 Oct - Dec;110(7-8):292-302.

2.

Chlamydia trachomatis respiratory infection in Dutch infants.

Rours GI, Hammerschlag MR, Van Doornum GJ, Hop WC, de Groot R, Willemse HF, Verbrugh HA, Verkooyen RP.

Arch Dis Child. 2009 Sep;94(9):705-7. doi: 10.1136/adc.2008.152066. Epub 2009 Apr 23.

PMID:
19395401
3.

Chlamydia trachomatis as a cause of neonatal conjunctivitis in Dutch infants.

Rours IG, Hammerschlag MR, Ott A, De Faber TJ, Verbrugh HA, de Groot R, Verkooyen RP.

Pediatrics. 2008 Feb;121(2):e321-6. doi: 10.1542/peds.2007-0153.

PMID:
18245405
4.

Use of pooled urine samples and automated DNA isolation to achieve improved sensitivity and cost-effectiveness of large-scale testing for Chlamydia trachomatis in pregnant women.

Rours GI, Verkooyen RP, Willemse HF, van der Zwaan EA, van Belkum A, de Groot R, Verbrugh HA, Ossewaarde JM.

J Clin Microbiol. 2005 Sep;43(9):4684-90.

5.

Cytomegalovirus and Chlamydia pneumoniae as predictors for adverse events and angina pectoris after percutaneous coronary intervention.

Rahel BM, Visseren FL, Suttorp MJ, Plokker TH, Kelder JC, de Jongh BM, Diepersloot RJ, Verkooyen RP, Bouter KP.

Am Heart J. 2004 Oct;148(4):670-5.

PMID:
15459599
6.

Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients.

Buljevac D, Verkooyen RP, Jacobs BC, Hop W, van der Zwaan LA, van Doorn PA, Hintzen RQ.

Ann Neurol. 2003 Dec;54(6):828-31.

PMID:
14681894
7.
8.

Prevalence of STD and HIV infections among attenders of the Erasmus MC STD clinic, Rotterdam, The Netherlands, during the years 1996 to 2000.

van der Snoek EM, Götz HM, Mulder PG, Verkooyen RP, van der Meijden WI.

Int J STD AIDS. 2003 Feb;14(2):119-24.

PMID:
12662391
9.

Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis.

Gerdes VE, Verkooyen RP, Kwa VI, de Groot E, van Gorp EC, ten Cate H, Brandjes DP, Büller HR.

Atherosclerosis. 2003 Mar;167(1):65-71.

PMID:
12618269
10.

Tubal factor pathology caused by Chlamydia trachomatis: the role of serology.

Mouton JW, Peeters MF, van Rijssort-Vos JH, Verkooyen RP.

Int J STD AIDS. 2002 Dec;13 Suppl 2:26-9.

PMID:
12537722
11.

Sensitivity and specificity of three new commercially available Chlamydia trachomatis tests.

Verkooyen RP, Peeters MF, van Rijsoort-Vos JH, van der Meijden WI, Mouton JW.

Int J STD AIDS. 2002 Dec;13 Suppl 2:23-5.

PMID:
12537721
12.

Foreword.

Verkooyen RP, Van Der Meijden WI.

Int J STD AIDS. 2002 Dec;13 Suppl 2(12):1. No abstract available.

PMID:
12537714
13.

Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization.

Dorigo-Zetsma JW, Verkooyen RP, van Helden HP, van der Nat H, van den Bosch JM.

J Clin Microbiol. 2001 Mar;39(3):1184-6.

14.

Impact of hospital-wide surveillance on hospital-acquired infections in an acute-care hospital in the Netherlands.

Mintjes-de Groot AJ, van Hassel CA, Kaan JA, Verkooyen RP, Verbrugh HA.

J Hosp Infect. 2000 Sep;46(1):36-42.

PMID:
11023721
15.

[Prevalence of sexually transmitted diseases (STD) and HIV-infection among attendees of STD Outpatient Clinic, Dijkzigt University Hospital in Rotterdam; comparative analysis of years 1993 and 1998].

van der Snoek EM, Chin-A-Lien RA, de Ridder MA, Willems PW, Verkooyen RP, van der Meijden WI.

Ned Tijdschr Geneeskd. 2000 Jul 8;144(28):1351-5. Dutch.

PMID:
10923157
16.

Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections.

Verkooyen RP, Willemse D, Hiep-van Casteren SC, Joulandan SA, Snijder RJ, van den Bosch JM, van Helden HP, Peeters MF, Verbrugh HA.

J Clin Microbiol. 1998 Aug;36(8):2301-7.

17.

Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA.

Verkooyen RP, Van Lent NA, Mousavi Joulandan SA, Snijder RJ, van den Bosch JM, Van Helden HP, Verbrugh HA.

J Med Microbiol. 1997 Nov;46(11):959-64.

PMID:
9368538
18.

Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.

Goessens WH, Mouton JW, van der Meijden WI, Deelen S, van Rijsoort-Vos TH, Lemmens-den Toom N, Verbrugh HA, Verkooyen RP.

J Clin Microbiol. 1997 Oct;35(10):2628-33.

19.

Widely used, commercially available Chlamydia pneumoniae antigen contaminated with mycoplasma.

Verkooyen RP, Sijmons M, Fries E, Van Belkum A, Verbrugh HA.

J Med Microbiol. 1997 May;46(5):419-24.

PMID:
9152039
20.

Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay.

Verkooyen RP, Luijendijk A, Huisman WM, Goessens WH, Kluytmans JA, van Rijsoort-Vos JH, Verbrugh HA.

J Clin Microbiol. 1996 Dec;34(12):3072-4.

21.

Survival of Chlamydia pneumoniae following contact with various surfaces.

Verkooyen RP, Harreveld S, Ahmad Mousavi Joulandan S, Diepersloot RJ, Verbrugh HA.

Clin Microbiol Infect. 1995 Feb;1(2):114-118.

22.

Mesothelial cell adherence to vascular prostheses and their subsequent growth in vitro.

Pronk A, Hoynck van Papendrecht AA, Leguit P, Verbrugh HA, Verkooyen RP, van Vroonhoven TJ.

Cell Transplant. 1994 Jan-Feb;3(1):41-8.

PMID:
8162292
23.

Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor.

Verkooyen RP, Hazenberg MA, Van Haaren GH, Van Den Bosch JM, Snijder RJ, Van Helden HP, Verbrugh HA.

J Clin Microbiol. 1992 May;30(5):1287-90.

24.

Prophylactic ciprofloxacin for catheter-associated urinary-tract infection.

van der Wall E, Verkooyen RP, Mintjes-de Groot J, Oostinga J, van Dijk A, Hustinx WN, Verbrugh HA.

Lancet. 1992 Apr 18;339(8799):946-51.

PMID:
1348797
25.

Impact of concurrent antimicrobial therapy on catheter-associated urinary tract infection.

Hustinx WN, Mintjes-de Groot AJ, Verkooyen RP, Verbrugh HA.

J Hosp Infect. 1991 May;18(1):45-56.

PMID:
1679071
26.

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone.

ter Braak EW, de Vries PJ, Bouter KP, van der Vegt SG, Dorrestein GC, Nortier JW, van Dijk A, Verkooyen RP, Verbrugh HA.

Am J Med. 1990 Jul;89(1):58-66.

PMID:
2195890
27.

[Registration and prevention of hospital infections in a general hospital].

Verbrugh HA, Mintjes-de Groot AJ, Verkooyen RP.

Ned Tijdschr Geneeskd. 1990 Mar 10;134(10):490-5. Dutch.

PMID:
2314490
28.

Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections.

de Vries PJ, Verkooyen RP, Leguit P, Verbrugh HA.

Eur J Clin Microbiol Infect Dis. 1990 Mar;9(3):161-8.

PMID:
2186909
29.

Adherence of peritonitis-causing staphylococci to human peritoneal mesothelial cell monolayers.

Haagen IA, Heezius HC, Verkooyen RP, Verhoef J, Verbrugh HA.

J Infect Dis. 1990 Feb;161(2):266-73.

PMID:
2299208
30.

Host defence in CAPD treatment: the effect of the dialysate on cell function.

van Bronswijk H, Verbrugh HA, Heezius EC, Verkooyen RP, van der Meulen J, Verhoef J.

Contrib Nephrol. 1990;85:67-72. Review. No abstract available.

PMID:
2078941
31.

Widal-type serology using live antigen for diagnosis of Shigella flexneri dysentery.

Verbrugh HA, Mekkes DR, Verkooyen RP, Landheer JE.

Eur J Clin Microbiol. 1986 Oct;5(5):540-2. No abstract available.

PMID:
3536499

Supplemental Content

Loading ...
Support Center